Mindscape Collective is now The Consciousness Library. Same library, new name. You may need to sign in again. About the change
Skip to content

Marine Inspired 2-(5-Halo-1H-indol-3-yl)-N,N-dimethylethanamines as Modulators of Serotonin Receptors: An Example Illustrating the Power of Bromine as Part of the Uniquely Marine Chemical Space

Mohamed A. Ibrahim, Abir T. El-Alfy, Kelly Ezel, Mohamed O. Radwan, Abbas G. Shilabin, Anna J. Kochanowska-Karamyan, Howaida I. Abd-Alla, Masami Otsuka, Mark T. Hamann

Marine Drugs October 26, 2018 DOI: 10.3390/md15080248 (opens in new tab) via DOAJ

Summary

AI-generated from the abstract

Several halogen-substituted tryptamine compounds were synthesized and tested for antidepressant and sedative effects in mice. Six compounds—1a, 1d, 2a, 2c, 2d, and 2e—showed significant antidepressant-like action in the forced swim test, while three (2c, 2d, 2e) also exhibited potent sedative activity in the locomotor activity test. Compounds 2a, 2c, 2d, and 2e bound to serotonin receptors 5-HT1A and 5-HT7 with nanomolar affinities. The in vitro data suggests that the antidepressant effects are mediated, at least in part, through interaction with serotonin receptors. Bromine substitutions were highlighted as valuable for creating novel chemical interactions.

Study at a glance

Characteristics Experimental study Peer reviewed
Population Mice
Interventions 2-(1H-indol-3-yl)-N N-dimethyl-2-oxoacetamide (1a) 2-(5-bromo-1H-indol-3-yl)-N N-dimethyl-2-oxoacetamide (1d) N-dimethylethanamine (2a) 2-(5-chloro-1H-indol-3-yl)-N N-dimethylethanamine (2c) N-dimethylethanamine (2d) 2-(5-iodo-1H-indol-3-yl)-N N-dimethylethanamine (2e)
Keywords Serotonin receptors Psychiatric disorders 5-Halo N,N-Dimethyltryptamine
Citations 22
Key finding Six halogen-substituted tryptamine compounds showed significant antidepressant-like action in mice, with three also exhibiting potent sedative activity, and four compounds bound to serotonin receptors 5-HT1A and 5-HT7 with nanomolar affinities.

Abstract

In previous studies, we have isolated several marine indole alkaloids and evaluated them in the forced swim test (FST) and locomotor activity test, revealing their potential as antidepressant and sedative drug leads. Amongst the reported metabolites to display such activities was 5-bromo-N,N-dimethyltryptamine. Owing to the importance of the judicious introduction of halogens into drug candidates, we synthesized two series built on a 2-(1H-indol-3-yl)-N,N-dimethylethanamine scaffold with different halogen substitutions. The synthesized compounds were evaluated for their in vitro and in vivo antidepressant and sedative activities using the mouse forced swim and locomotor activity tests. Receptor binding studies of these compounds to serotonin (5-HT) receptors were conducted. Amongst the prepared compounds, 2-(1H-indol-3-yl)-N,N-dimethyl-2-oxoacetamide (1a), 2-(5-bromo-1H-indol-3-yl)-N,N-dimethyl-2-oxoacetamide (1d), 2-(1H-indol-3-yl)-N,N-dimethylethanamine (2a), 2-(5-chloro-1H-indol-3-yl)-N,N-dimethylethanamine (2c), 2-(5-bromo-1H-indol-3-yl)-N,N-dimethylethanamine (2d), and 2-(5-iodo-1H-indol-3-yl)-N,N-dimethylethanamine (2e) have been shown to possess significant antidepressant-like action, while compounds 2c, 2d, and 2e exhibited potent sedative activity. Compounds 2a, 2c, 2d, and 2e showed nanomolar affinities to serotonin receptors 5-HT1A and 5-HT7. The in vitro data indicates that the antidepressant action exerted by these compounds in vivo is mediated, at least in part, via interaction with serotonin receptors. The data presented here shows the valuable role that bromine plays in providing novel chemical space and electrostatic interactions. Bromine is ubiquitous in the marine environment and a common element of marine natural products.

Comments

No comments yet.

Log in to comment